STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 80 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 4.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,834,000 | -54.5% | 998,677 | 0.0% | 0.07% | -47.2% |
| Q4 2019 | $10,616,000 | +2.1% | 998,677 | 0.0% | 0.13% | -3.8% |
| Q3 2019 | $10,396,000 | -20.9% | 998,677 | +16.4% | 0.13% | -19.0% |
| Q2 2019 | $13,146,000 | +185.7% | 858,082 | +139.6% | 0.16% | +181.0% |
| Q1 2019 | $4,601,000 | +265.7% | 358,082 | +170.4% | 0.06% | +222.2% |
| Q4 2018 | $1,258,000 | -57.8% | 132,428 | -26.2% | 0.02% | -52.6% |
| Q3 2018 | $2,978,000 | -13.2% | 179,409 | -16.0% | 0.04% | -20.8% |
| Q2 2018 | $3,430,000 | +31.9% | 213,706 | +25.7% | 0.05% | +20.0% |
| Q1 2018 | $2,601,000 | -14.7% | 169,995 | -13.0% | 0.04% | -9.1% |
| Q4 2017 | $3,049,000 | +71.7% | 195,437 | +22.1% | 0.04% | +76.0% |
| Q3 2017 | $1,776,000 | +387.9% | 160,000 | +649.4% | 0.02% | +400.0% |
| Q4 2014 | $364,000 | +37.4% | 21,350 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $265,000 | – | 21,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 453,000 | $4,168,000 | 1.58% |
| Eventide Asset Management | 1,086,400 | $9,995,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $2,760,000 | 0.47% |
| Lyon Street Capital, LLC | 125,595 | $1,155,000 | 0.46% |
| CARL DOMINO INC | 26,000 | $239,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $552,000 | 0.22% |
| KNOTT DAVID M | 41,692 | $384,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 187,500 | $1,725,000 | 0.11% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,157,500 | $10,649,000 | 0.11% |
| Telemetry Investments, L.L.C. | 25,000 | $230,000 | 0.11% |